These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21631263)

  • 1. Update on precursor and early lesions of hepatocellular carcinomas.
    Park YN
    Arch Pathol Lab Med; 2011 Jun; 135(6):704-15. PubMed ID: 21631263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latest developments in precancerous lesions of hepatocellular carcinoma.
    Niu ZS; Niu XJ; Wang WH; Zhao J
    World J Gastroenterol; 2016 Mar; 22(12):3305-14. PubMed ID: 27022212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic precancerous lesions and small hepatocellular carcinoma.
    Hytiroglou P; Park YN; Krinsky G; Theise ND
    Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study].
    Chen L; Tan Y; Zeng H; Hou Y; Xu J; Zhao J; Ji Y
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):301-6. PubMed ID: 25030861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular dysplastic nodules.
    Roncalli M; Borzio M; Di Tommaso L
    Ann Ital Chir; 2008; 79(2):81-9. PubMed ID: 18727269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver precancerous lesions and hepatocellular carcinoma: the histology report.
    Roncalli M; Terracciano L; Di Tommaso L; David E; Colombo M; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S361-72. PubMed ID: 21459342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma.
    Chen D; Li Z; Zhu W; Cheng Q; Song Q; Qian L; Zhu JY
    J Clin Pathol; 2019 Apr; 72(4):295-303. PubMed ID: 30610005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological changes of early human hepatocarcinogenesis.
    Hytiroglou P
    Semin Liver Dis; 2004 Feb; 24(1):65-75. PubMed ID: 15085487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
    Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
    Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocarcinogenesis in human liver].
    Nagy P; László V; Schaff Z
    Magy Onkol; 2006; 50(2):107-13. PubMed ID: 16888673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint.
    Kojiro M
    J Hepatobiliary Pancreat Surg; 2000; 7(6):535-41. PubMed ID: 11180884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytological characteristics of small cell change of dysplasia in small hepatic nodules.
    Chang O; Yano Y; Masuzawa A; Fukushima N; Teramura K; Hayashi Y
    Oncol Rep; 2010 May; 23(5):1229-32. PubMed ID: 20372834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preneoplastic lesions in human hepatocarcinogenesis.
    Libbrecht L; Desmet V; Roskams T
    Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.
    Park YN; Kojiro M; Di Tommaso L; Dhillon AP; Kondo F; Nakano M; Sakamoto M; Theise ND; Roncalli M
    Cancer; 2007 Mar; 109(5):915-23. PubMed ID: 17279586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions.
    Ojima H; Masugi Y; Tsujikawa H; Emoto K; Fujii-Nishimura Y; Hatano M; Kawaida M; Itano O; Kitagawa Y; Sakamoto M
    Cancer Sci; 2016 Apr; 107(4):543-50. PubMed ID: 26797961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
    Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
    Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
    Osada T; Sakamoto M; Nishibori H; Iwaya K; Matsuno Y; Muto T; Hirohashi S
    J Hepatol; 1997 Jun; 26(6):1266-73. PubMed ID: 9210613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.
    Frachon S; Gouysse G; Dumortier J; Couvelard A; Nejjari M; Mion F; Berger F; Paliard P; Boillot O; Scoazec JY
    J Hepatol; 2001 Jun; 34(6):850-7. PubMed ID: 11451168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.